Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04034225
Title Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sensei Biotherapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California - San Francisco San Francisco California 94143 United States Details
Christiana Care Newark Delaware 19713 United States Details
Georgetown University Washington District of Columbia 20057 United States Details
Emory University Atlanta Georgia 30322 United States Details
Rush University Chicago Illinois 60612 United States Details
Alliance for Multispeciality Research Kansas City Missouri 64114 United States Details
Mt. Sinai New York New York 10029 United States Details
New Orleans Clinical Research Knoxville Tennessee 37920 United States Details
Clear Lake Specialties Webster Texas 77598 United States Details
University of Wisconsin Madison Wisconsin 53715 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field